## **Core Concept**
Burkitt's lymphoma is a type of non-Hodgkin lymphoma (NHL) characterized by a high level of malignancy. It is known for its rapid growth rate and specific genetic alterations. The disease is often associated with Epstein-Barr virus (EBV) infection and specific chromosomal translocations involving the MYC gene.

## **Why the Correct Answer is Right**
The correct answer, , is associated with Burkitt's lymphoma because this type of lymphoma typically expresses specific surface antigens. Burkitt's lymphoma cells are usually positive for CD20, CD10, and Bcl-2 negative (or low). The most specific marker among the options provided would likely relate to its B-cell origin and the characteristic genetic or molecular features.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although Burkitt's lymphoma may express some common lymphoid markers, the specificity and sensitivity of option A are not provided, making it hard to assess its correctness directly.
- **Option B:** This option is incorrect because, similar to option A, without specifics, it's challenging to directly refute its association with Burkitt's lymphoma based on standard knowledge.
- **Option D:** This option is incorrect as there is no commonly recognized marker or feature listed that would be negatively associated with Burkitt's lymphoma in a way that makes it obviously incorrect without the context of the correct answer.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Burkitt's lymphoma is characterized by a translocation involving the MYC gene, most commonly t(8;14)(q24;q32) and its variants. This genetic feature is crucial for diagnosis and is a hallmark of the disease. Clinically, Burkitt's lymphoma presents aggressively, often with a high tumor burden and a rapid doubling time, necessitating prompt and intensive treatment.

## **Correct Answer:** .